2024-12-05 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**1. Performance Comparison and Outperformance:**

Intuitive Surgical Inc. (ISRG) is a company that manufactures and sells da Vinci surgical systems and related instruments.  Its cumulative return significantly outperforms the S&P 500 (VOO).  The final cumulative return difference between ISRG and VOO is 204.1%, placing it at the 94.4th percentile of its historical range relative to the S&P 500.  This indicates a substantial outperformance over the analyzed period.  The provided alpha values consistently show 0.0 which could either mean the data is incomplete or the alpha was calculated without a risk-free rate of return. The beta values are generally high, indicating high sensitivity to market movements.


**2. Recent Price Movement:**

* **Closing Price:** 541.71
* **5-Day Moving Average:** 541.44
* **20-Day Moving Average:** 536.05
* **60-Day Moving Average:** 507.33

The price is slightly above the 5-day moving average, suggesting recent stability.  It’s above both the 20-day and 60-day moving averages, indicating an upward trend over the medium and long term. The last market price of 549.41 suggests a recent slight dip.


**3. Technical Indicators and Expected Return:**

* **RSI (Relative Strength Index):** 53.67 – This suggests the stock is neither overbought nor oversold, implying a neutral short-term outlook.
* **PPO (Price Oscillator):** -0.225 – A negative value indicates bearish momentum, although the magnitude is relatively small.
* **Delta_Previous_Relative_Divergence:** nan (Not Available)- Lack of data prevents analysis.
* **Expected Return:** 123.9% –  This represents a significant long-term (2+ years) outperformance potential relative to the S&P 500, assuming consistent outperformance, however this should be viewed with caution due to market volatility and the lack of explanation regarding the calculation methodology for this metric.

The provided information is inconclusive.


**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue     |
|------------|--------|-------------|
| 2024-10-18 | 1.59   | $2.04 B     |
| 2024-07-19 | 1.48   | $2.01 B     |
| 2024-04-19 | 1.54   | $1.89 B     |
| 2023-10-20 | 1.18   | $1.74 B     |
| 2024-10-18 | 1.18   | $1.74 B     | *(Duplicate Entry - Assumed typo, only using one entry)*


* **Latest Quarterly Results:** The most recent quarter (2024-10-18) shows an increase in EPS (1.59 vs 1.48 in the prior quarter) and revenue ($2.04B vs $2.01B).
* **Revenue Growth Trends:** Revenue shows relatively consistent growth, with a minor dip in Q4 2023 and a recent upturn.
* **EPS Trends:** EPS is showing some volatility but a general upward trend over the observed period.  The duplicate data point makes analysis incomplete and potentially unreliable.
* **Beats or Misses:** No information on expectations is available to determine beats or misses.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2024-09-30   | $2.04B    | 67.41%         |
| 2024-06-30   | $2.01B    | 68.30%         |
| 2024-03-31   | $1.89B    | 65.87%         |
| 2023-12-31   | $1.93B    | 66.24%         |
| 2023-09-30   | $1.74B    | 66.94%         |

Profit margins are generally stable and high, demonstrating strong profitability. Revenue growth is relatively consistent.

**Capital and Profitability:**

| Quarter      | Equity     | ROE          |
|--------------|------------|--------------|
| 2024-09-30   | $15.58B   | 3.63%        |
| 2024-06-30   | $14.71B   | 3.58%        |
| 2024-03-31   | $13.96B   | 3.90%        |
| 2023-12-31   | $13.31B   | 4.56%        |
| 2023-09-30   | $12.54B   | 3.32%        |

Equity shows consistent growth. ROE fluctuates, but generally maintains a positive trend.

**6. News and Recent Issues:**

No information regarding recent news (within the last 2 days) , market outlook, or analyst opinions was provided.  Therefore, no analysis can be performed on this section.

**7. Overall Analysis:**

ISRG significantly outperforms the S&P 500 over the analyzed period, exhibiting strong historical performance.  Recent price movement shows an upward trend, while technical indicators offer a neutral to slightly bearish short-term outlook. Financial statements indicate robust profitability and consistent revenue growth, alongside steady equity growth and a generally positive ROE. However, critical data points are missing, including the calculation method for the 123.9% expected return, complete relative divergence calculations, and recent news/analyst sentiment.  More detailed and complete data is required for a comprehensive assessment.  The duplicate entry in the earnings analysis raises questions about data accuracy.  This analysis should be supplemented with additional information for a complete picture.


**8. Disclaimer:** This report is for informational purposes only and does not constitute financial advice.  Investing in the stock market involves risk, and past performance is not indicative of future results.  Always conduct thorough research and consult with a qualified financial advisor before making any investment decisions.
